Chemistry: analytical and immunological testing – Lipids – triglycerides – cholesterol – or lipoproteins
Patent
1992-10-30
1995-01-10
Housel, James C.
Chemistry: analytical and immunological testing
Lipids, triglycerides, cholesterol, or lipoproteins
436 63, 436 86, 436 97, G01N 3392
Patent
active
053806670
ABSTRACT:
A new series of non-lipid risk factors for predicting coronary artery disease (CAD) are disclosed. The level of serum total bilirubin was found to be a statistically significant independent risk factor for CAD and to be inversely related to CAD. Similarly, the levels of fasting blood sugar, serum glutamate pyruvate transaminase and the ratio of total cholesterol to serum total bilirubin were found to be significant univariate predictors of CAD.
REFERENCES:
patent: 3715188 (1973-02-01), Denny
patent: 4464388 (1984-08-01), Sakai et al.
patent: 4672041 (1987-06-01), Jain
patent: 4683208 (1987-07-01), Aoyama et al.
patent: 4788153 (1988-11-01), Detwiler et al.
patent: 4863873 (1989-09-01), Matson
patent: 4965210 (1990-10-01), Modrovich
patent: 5032608 (1991-07-01), Dudrick
patent: 5112827 (1992-05-01), Saunders et al.
Robert Berkow, The Merch Manual of Diagnosis and Therapy, 1987 p. 2413.
Y. Adachi, H. Inufusa, M. Yamashita, A. Kambe, K. Yamazaki, Y. Sawada and T. Yamamoto, Clinical Application of Serum Bilirubin Fractionation by Simplified Liquid Chromatography, 1988, vol. 34, No. 2 pp. 385-388.
B. T. Doumas and Tai-Wing Wu, The Measurement of Bilirubin Fractions in Serum, Critical Reviews in Clinical Laboratory Sciences, 1991, vol. 28 Nos. 5 and 6, pp. 415-445.
J. J. Lauff, M. E. Kasper and R. T. Ambrose, Quantitative Liquid-Chromatographic Estimation of Bilirubin Species in Pathological Serum, 1983, vol. 29, No. 5, pp. 800-805.// K. P. M. Heirwegh, J. Fevery & N. Blanckaert Chromatographic Analysis & Structure Determination of biliverdins & Bilirubins 1989, vol. 496, pp. 1-26.
Bhat N.
Housel James C.
Kundert Thomas L.
Sinder Fredric L.
The United States of America as represented by the Secretary of
LandOfFree
Serum bilirubin and liver function tests as risk predictors for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serum bilirubin and liver function tests as risk predictors for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum bilirubin and liver function tests as risk predictors for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-850307